Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,015 | 104,749 | 97,068 | 90,690 | 107,658 |
| TOTAL | $278,197 | $107,393 | $102,715 | $92,673 | $109,668 |
| Non-Current Assets | |||||
| PPE Net | 129 | 141 | 88 | 71 | 42 |
| Other Non-Current Assets | 1,674 | 1,833 | 1,424 | 1,633 | 853 |
| TOTAL | $1,803 | $1,974 | $1,512 | $1,704 | $895 |
| Total Assets | $280,000 | $109,367 | $104,227 | $94,377 | $110,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,798 | 2,158 | 846 | 1,548 | 2,522 |
| Accrued Expenses | 11,282 | 10,726 | 7,781 | 7,913 | 6,364 |
| TOTAL | $13,080 | $12,884 | $8,627 | $9,461 | $8,886 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,862 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 436 | 485 | 543 | 650 | 122 |
| TOTAL | $5,298 | $485 | $543 | $650 | $122 |
| Total Liabilities | $18,378 | $13,369 | $9,170 | $10,111 | $9,008 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,419 | 23,665 | 15,055 | 12,561 | 12,350 |
| Common Shares | 24 | 16 | 14 | 12 | 12 |
| Retained earnings | -969,176 | -941,248 | -915,781 | -887,134 | -866,504 |
| TOTAL | $261,622 | $95,998 | $95,057 | $84,266 | $101,555 |
| Total Liabilities And Equity | $280,000 | $109,367 | $104,227 | $94,377 | $110,563 |